| 25 May 2026 |
Vilon |
5.4 |
30mg |
36.4mg |
+21.5% |
99.20% |
Lab E |
| 24 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
7.5 |
20mg |
18.6mg |
-7.0% |
95.36% |
Lab E |
| 24 May 2026 |
KissPeptin-10 |
9.8 |
5mg |
4.6mg |
-8.0% |
97.77% |
Lab A |
| 24 May 2026 |
MOTS-C |
4.8 |
20mg |
23.0mg |
+15.0% |
97.31% |
Lab G |
| 23 May 2026 |
N-Acetyl Epitalon Amidate |
7.8 |
30mg |
26.3mg |
-12.5% |
98.56% |
Lab D |
| 21 May 2026 |
DHB (1-Test Cyp) Oral |
7.3 |
50mg |
46.8mg |
-6.3% |
97.60% |
Lab A |
| 20 May 2026 |
Chonluten |
5.3 |
20mg |
23.7mg |
+18.7% |
95.53% |
Lab F |
| 19 May 2026 |
SR9009 |
5.8 |
50mg |
42.8mg |
-14.3% |
95.27% |
Lab C |
| 17 May 2026 |
Enclomiphene |
4.0 |
10mg |
10.9mg |
+9.3% |
96.28% |
Lab G |
| 17 May 2026 |
HGH Fragment 176-191 |
7.0 |
2mg |
2.1mg |
+5.1% |
98.15% |
Lab A |
| 17 May 2026 |
Humanin |
8.0 |
20mg |
24.7mg |
+23.7% |
98.26% |
Lab B |
| 17 May 2026 |
Thymalin |
4.0 |
5mg |
6.0mg |
+20.6% |
95.01% |
Lab A |
| 29 Jan 2026 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
4.0 |
15mg |
18.7mg |
+24.7% |
99.62% |
Lab E |
| 26 Jan 2026 |
Blend 500 (Tren E/Mast E) |
6.3 |
200mg/ml |
178.3mg/ml |
-10.9% |
99.20% |
Lab B |
| 26 Jan 2026 |
Crystagen |
5.0 |
10mg |
9.0mg |
-9.7% |
96.30% |
Lab G |
| 26 Jan 2026 |
Livagen |
4.0 |
20mg |
20.8mg |
+4.0% |
99.24% |
Lab G |
| 26 Jan 2026 |
Nandrolone Decanoate (Deca) Raw |
5.2 |
100g |
85.2g |
-14.8% |
96.94% |
Lab F |
| 26 Jan 2026 |
Ostarine (MK-2866) |
8.2 |
10mg |
9.3mg |
-7.0% |
99.91% |
Lab F |
| 9 Jan 2026 |
Ovagen |
5.5 |
5mg |
4.9mg |
-2.4% |
96.87% |
Lab E |
| 7 Jan 2026 |
ACE-031 |
5.7 |
30mg |
33.2mg |
+10.8% |
98.45% |
Lab E |
| 7 Jan 2026 |
Clenbuterol |
6.0 |
100mg |
97.0mg |
-3.0% |
95.55% |
Lab A |
| 30 Dec 2025 |
Tirzepatide |
7.3 |
30mg |
34.1mg |
+13.7% |
99.71% |
Lab E |
| 29 Dec 2025 |
Retatrutide |
7.8 |
20mg |
22mg |
+10.0% |
99.60% |
Lab G |
| 29 Dec 2025 |
Abaloparatide |
7.2 |
15mg |
18.2mg |
+21.6% |
95.79% |
Lab B |
| 29 Dec 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
9.0 |
10g |
10.9g |
+8.7% |
98.85% |
Lab E |
| 12 Dec 2025 |
Ivermectin |
8.1 |
100mg |
98.2mg |
-1.8% |
95.45% |
Lab D |
| 12 Dec 2025 |
Oxytocin Acetate |
4.0 |
20mg |
18.7mg |
-6.3% |
97.09% |
Lab F |
| 11 Dec 2025 |
Retatrutide |
10.0 |
10mg |
10.4mg |
+4.0% |
99.92% |
Lab E |
| 11 Dec 2025 |
Tirzepatide |
9.5 |
60mg |
63.9mg |
+6.5% |
99.95% |
Lab E |
| 5 Dec 2025 |
Testosterone Decanoate Raw |
4.0 |
100g |
118.8g |
+18.8% |
96.07% |
Lab C |
| 23 Nov 2025 |
Andarine S4 |
4.0 |
100mg |
119.8mg |
+19.8% |
96.91% |
Lab E |
| 23 Nov 2025 |
APAA (alpha-phenylacetoacetamide) CAS 102-01-2 |
5.5 |
1g |
1.0g |
+1.4% |
98.68% |
Lab E |
| 23 Nov 2025 |
Vitamin B12 10mg/ml |
6.0 |
200mg/ml |
247.6mg/ml |
+23.8% |
97.80% |
Lab D |
| 5 Nov 2025 |
Proviron (Mesterolone) Raw |
6.9 |
1g |
1.2g |
+20.6% |
97.29% |
Lab B |
| 4 Nov 2025 |
EPO |
7.5 |
50mg |
60.8mg |
+21.6% |
98.38% |
Lab B |
| 4 Nov 2025 |
Halotestin (Fluoxymesterone) |
5.1 |
100mg |
91.0mg |
-9.0% |
95.49% |
Lab D |
| 9 Oct 2025 |
BPC157 5mg + TB500 5mg Blend |
8.4 |
5mg |
5.9mg |
+17.3% |
99.08% |
Lab B |
| 9 Oct 2025 |
Cartalax |
4.0 |
5mg |
5.0mg |
+0.2% |
99.36% |
Lab A |
| 9 Oct 2025 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
4.0 |
10mg |
9.5mg |
-4.6% |
95.55% |
Lab C |
| 9 Oct 2025 |
PTD-DBM |
4.0 |
30mg |
26.0mg |
-13.4% |
98.16% |
Lab C |
| 9 Oct 2025 |
Semaglutide Raw |
6.8 |
100g |
102.0g |
+2.0% |
96.67% |
Lab D |
| 3 Oct 2025 |
MT-1 |
4.9 |
20mg |
21.3mg |
+6.6% |
96.57% |
Lab G |
| 1 Sep 2025 |
Retatrutide |
4.7 |
5mg |
5.68mg |
+13.6% |
99.45% |
Lab F |
| 4 Aug 2025 |
Retatrutide |
5.5 |
10mg |
9.89mg |
-1.1% |
98.52% |
Lab E |
| 25 Jul 2025 |
Tirzepatide |
7.8 |
30mg |
29.7mg |
-1.0% |
99.82% |
Lab E |